Routinely applicable, highly multiplexed triple-negative breast cancer (TNBC) genotyping

被引：0
|
作者：
Kotoula, Vassiliki [1 ]
Papadopoulou, Kyriaki [1 ]
Charalambous, Elpida [1 ]
Zagouri, Flora [1 ]
Lakis, Sotiris [1 ]
Lymperopoulou, Angeliki [1 ]
Tsolaki, Eleftheria [1 ]
Pentheroudakis, George [1 ]
Lilakos, Kostas [1 ]
Pectasides, Dimitrios [1 ]
Fountzilas, George [1 ]
机构：
[1] Hellen Cooperat Oncol Grp HeCOG, Athens, Greece
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-3579
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3579
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Mutational analysis of triple-negative breast cancer (TNBC): CALGB 40603 (Alliance)
    Hoadley, Katherine A.
    Powell, Bradford C.
    Kanavy, Dona
    Marron, David
    Mose, Lisle E.
    Hyslop, Terry
    Berry, Donald A.
    Hahn, Olwen
    Tolaney, Sara M.
    Sikov, William M.
    Perou, Charles M.
    Carey, Lisa A.
    CANCER RESEARCH, 2020, 80 (04)
  • [22] Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC)
    Mohd Mustafa
    Kashif Abbas
    Mudassir Alam
    Waleem Ahmad
    Nazura Moinuddin
    Shahid Ali Usmani
    Safia Siddiqui
    Molecular and Cellular Biochemistry, 2024, 479 : 895 - 913
  • [23] RADIOLOGICAL-HISTOLOGICAL SIZE CORRELATION IN TRIPLE-NEGATIVE BREAST CANCER (TNBC)
    Thibault, C.
    Gosset, M.
    Chamming'S, F.
    Lefrere-Belda, M.
    Pecuchet, N.
    Fournier, L.
    Roussel, H.
    Oudard, S.
    Lecuru, F.
    Medioni, J.
    ANNALS OF ONCOLOGY, 2014, 25
  • [24] Copper chaperons as novel targets for therapy in triple-negative breast cancer (TNBC)
    Karginova, O.
    Song, A.
    Wang, J.
    Luo, C.
    Jiang, H.
    He, C.
    Olopade, O. I.
    CANCER RESEARCH, 2016, 76
  • [25] Alignment of patient-clinician perspectives in triple-negative breast cancer (TNBC).
    Ackbarali, Tariqa
    Goins, Chelsey
    Walker, Stephanie
    Donahue, Sara
    Witt, Jennifer
    Vidal, Gregory A.
    Traina, Tiffany A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] A Phase II study of cabozantinib for metastatic triple-negative breast cancer (TNBC).
    Tolaney, Sara M.
    Ziehr, David R.
    Guo, Hao
    Barry, William Thomas
    Higgins, Michaela Jane
    Isakoff, Steven J.
    Brock, Jane E.
    Ivanova, Elena
    Paweletz, Cloud
    Demeo, Michelle
    Ramaiya, Nikhil H.
    Overmoyer, Beth
    Jain, Rakesh K.
    Duda, Dan G.
    Winer, Eric P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [27] Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
    Chaudhuri, Aiswarya
    Kumar, Dulla Naveen
    Dehari, Deepa
    Singh, Sanjay
    Kumar, Pradeep
    Bolla, Pradeep Kumar
    Kumar, Dinesh
    Agrawal, Ashish Kumar
    PHARMACEUTICALS, 2022, 15 (05)
  • [28] The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)
    Farghadani, Reyhaneh
    Naidu, Rakesh
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 165
  • [29] Defining triple-negative breast cancer with neuroendocrine differentiation (TNBC-NED)
    Hacking, Sean M.
    Yakirevich, Evgeny
    Wang, Yihong
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2023, 9 (04): : 313 - 321
  • [30] Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC)
    Mustafa, Mohd
    Abbas, Kashif
    Alam, Mudassir
    Ahmad, Waleem
    Moinuddin
    Usmani, Nazura
    Siddiqui, Shahid Ali
    Habib, Safia
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, 479 (04) : 895 - 913
12345